PathMap Literature Based Discovery Engine
Share your Discovery:
Guaranteed to find unpublished literature based discoveries.
Breakthroughs is bulbar palsy found in PubMed Literature, July 2026.


Can fatty liver disease be treated in order to restore gut health?


MASLD pathophysiology
_gates_from_masld_pathophysiology
Gastrointestinal Microbiome
_gates_to_gastrointestinal_microbiome
_gates_from_gastrointestinal_microbiome
Farnesoid X-Activated Receptor
_gates_to_farnesoid_x_activated_receptor
_gates_from_farnesoid_x_activated_receptor
Intestinal Mucosa
_gates_to_intestinal_mucosa
The ALS-T2D comorbidity is driven by a bidirectional, exosome-mediated proteostatic collapse. Peripheral tissues (muscle, pancreas) dictate CNS TDP-43 stability via exosomal miRNAs (miR-126a-5p) and glucose-dependent modifications (O-GlcNAcylation). Conversely, pharmacological activation of ubiquitin-peptidases (e.g., Acarbose targeting USP46) or restitution of glycolytic cofactors (F2,6BP) represent novel, cross-disciplinary therapeutic targets capable of halting systemic proteinopathy.


Diabetes Mellitus, Type 2
_gates_from_diabetes_mellitus__type_2
Extracellular Vesicles
_gates_to_extracellular_vesicles
_gates_from_extracellular_vesicles
DNA-Binding Proteins
_gates_to_dna_binding_proteins
_gates_from_dna_binding_proteins
Amyotrophic Lateral Sclerosis
_gates_to_amyotrophic_lateral_sclerosis
What is Karyoptosis and how does it align with past and present neurodegenerative disease research? Does Karyoptosis provide a new context in which a new class of repurposed therapeutics is formed?


Proteotoxic Stress
_gates_from_proteotoxic_stress
Cyclic AMP-Response Element Binding Protein
_gates_to_cyclic_amp_response_element_binding_protein
_gates_from_cyclic_amp_response_element_binding_protein
Nuclear Envelope
_gates_to_nuclear_envelope
_gates_from_nuclear_envelope
Apoptosis
_gates_to_apoptosis
Why are frontotemporal dementia and c9orf72 ALS considered different diseases if they are both driven by the same abnormal expansion of a GGGGCC (G₄C₂) sequence in the first intron of the C9orf72 gene? Is it logical to think that CRISPR therapeutics for FTD potentially be used for ALS as well?


C9orf72 expansion
_gates_from_c9orf72_expansion
Gene Expression Regulation
_gates_to_gene_expression_regulation
_gates_from_gene_expression_regulation
Protein Aggregation, Pathological
_gates_to_protein_aggregation__pathological
_gates_from_protein_aggregation__pathological
CRISPR-Cas Systems
_gates_to_crispr_cas_systems
Need a custom Literature-Based Discovery?
Get 1-3 unpublished, new, novel, real and non-implausible literature based discoveries with each order of a PathMap Evaluation (3x) package.
Order a custom PathMap Evaluation (3x) - $29.99